BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36617376)

  • 1. Applications of continuous glucose monitoring across settings and populations: Report from the 23rd Hong Kong diabetes and cardiovascular risk factors-East meets west symposium.
    Oliver N; Chow E; Luk AOY; Murphy HR
    Diabet Med; 2023 May; 40(5):e15038. PubMed ID: 36617376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterising frailty, metrics of continuous glucose monitoring, and mortality hazards in older adults with type 2 diabetes on insulin therapy (HARE): a prospective, observational cohort study.
    Fung E; Lui LT; Huang L; Cheng KF; Lau GHW; Chung YT; Ahmadabadi BN; Xie S; Lee JSW; Hui E; So WY; Sung JJY; King I; Goggins WB; Chan Q; Järvelin MR; Ma RCW; Chow E; Kwok T
    Lancet Healthy Longev; 2021 Nov; 2(11):e724-e735. PubMed ID: 36098029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy.
    Rodbard D
    Diabetes Obes Metab; 2023 Feb; 25(2):596-601. PubMed ID: 36314133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
    Krajnc M; Kravos Tramšek NA
    Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.
    Jones LV; Ray A; Moy FM; Buckley BS
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009613. PubMed ID: 31120549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.
    Battelino T; Alexander CM; Amiel SA; Arreaza-Rubin G; Beck RW; Bergenstal RM; Buckingham BA; Carroll J; Ceriello A; Chow E; Choudhary P; Close K; Danne T; Dutta S; Gabbay R; Garg S; Heverly J; Hirsch IB; Kader T; Kenney J; Kovatchev B; Laffel L; Maahs D; Mathieu C; Mauricio D; Nimri R; Nishimura R; Scharf M; Del Prato S; Renard E; Rosenstock J; Saboo B; Ueki K; Umpierrez GE; Weinzimer SA; Phillip M
    Lancet Diabetes Endocrinol; 2023 Jan; 11(1):42-57. PubMed ID: 36493795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus.
    Di Mario C; Genovese S; Lanza GA; Mannucci E; Marenzi G; Sciatti E; Pitocco D;
    Cardiovasc Diabetol; 2022 Aug; 21(1):164. PubMed ID: 36030229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes management.
    Kong APS; Lim S; Yoo SH; Ji L; Chen L; Bao Y; Yeoh E; Chan SP; Wang CY; Mohan V; Cohen N; McGill MJ; Twigg SM
    Diabetes Res Clin Pract; 2023 Jul; 201():110718. PubMed ID: 37196707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond HbA
    Brown SA; Basu A; Kovatchev BP
    Diabet Med; 2019 Jun; 36(6):679-687. PubMed ID: 30848545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycaemia risk index uncovers distinct glycaemic variability patterns associated with remission status in type 1 diabetes.
    Zhong T; He B; Li X; Lei K; Tang R; Zhao B; Li X
    Diabetologia; 2024 Jan; 67(1):42-51. PubMed ID: 37889319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
    Feig DS; Donovan LE; Corcoy R; Murphy KE; Amiel SA; Hunt KF; Asztalos E; Barrett JFR; Sanchez JJ; de Leiva A; Hod M; Jovanovic L; Keely E; McManus R; Hutton EK; Meek CL; Stewart ZA; Wysocki T; O'Brien R; Ruedy K; Kollman C; Tomlinson G; Murphy HR;
    Lancet; 2017 Nov; 390(10110):2347-2359. PubMed ID: 28923465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positioning time in range in diabetes management.
    Advani A
    Diabetologia; 2020 Feb; 63(2):242-252. PubMed ID: 31701199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of medium-term metrics for assessing glucose homoeostasis: Usefulness, strengths and weaknesses.
    Monnier L; Colette C; Owens D
    Diabetes Metab; 2021 Mar; 47(2):101173. PubMed ID: 32561428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials.
    Elbalshy M; Haszard J; Smith H; Kuroko S; Galland B; Oliver N; Shah V; de Bock MI; Wheeler BJ
    Diabet Med; 2022 Aug; 39(8):e14854. PubMed ID: 35441743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.